Form 483

Laboratorios Zepol S.A. Form 483, 2023-11-17

FDA issued a Form 483 to Laboratorios Zepol S.A. on 2023-11-17 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Laboratorios Zepol S.A. · Curridabat, Costa Rica · Issued November 17, 2023

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Nov 2023
21 CFR 211.122(d)

Label storage access limited to authorized personnel

Cited by Alan P Kurtzberg

17 Nov 2023
21 CFR 211.160(a)

Lab controls established, including changes

Cited by Alan P Kurtzberg

17 Nov 2023
21 CFR 211.166(a)(2)

Stability sample storage conditions described

Cited by Alan P Kurtzberg

17 Nov 2023
21 CFR 211.192

Written record of investigation incomplete

Cited by Alan P Kurtzberg

17 Nov 2023
21 CFR 211.194(a)(4)

Complete Test Data

Cited by Alan P Kurtzberg

Inspected site

LZLaboratorios Zepol S.A.Curridabat, Costa Rica

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.122(d)Cited across public-safe Form 483 observations1x
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.80(d)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere